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A B S T R A C T 
Gardner syndrome (GS) is a genetic disease, with autosomal dominant transmission, being a phenotypic 
variant of familial adenomatous polyposis (FAP). FAP is manifested by the development of numerous 
adenomas in the rectum during adolescence, and in most cases, if not identified and treated at an early stage, 
lead to colorectal cancer. This syndrome has several phenotypic characteristics and among them some 
changes in the oral cavity. Thus, the dentist has a preponderant role in the detection of lesions that may be 
present in the oral cavity in order to make possible an early diagnosis of the disease. Some manifestations 
of GS are observed at the dental level. Around 30 to 75% of GS patients present dental anomalies including 
dental agenesis, including teeth, delays in teeth eruption, dentigerous cysts, odontomas, supernumerary 
teeth, root fusion and hypercementosis. It is possible to see a significant difference in the presence of dental 
problems between patients with GS and the general population. In order to reduce morbidity and mortality, 
several types of surgery are used to eliminate the risk of colorectal cancer, preserving neighbouring 
anatomical functions. 
 
                                          © 2019 Inês Lopes Cardoso. Hosting by Science Repository. All rights reserved  
Introduction 
 
Gardner syndrome (GS) is a genetic disease, with autosomal dominant 
transmission, being a phenotypic variant of familial adenomatous 
polyposis (FAP). FAP is manifested by the development of numerous 
rectal adenomas during adolescence which, in most cases and if not 
identified and treated at an early stage, can lead to colorectal cancer. FAP 
has an incidence of 1/8,300 at birth and affects equally both sexes. In 
2009, the prevalence of FAP was estimated at 1/11,300-37,600. FAP 
represents less than 1% of colorectal cancers [1]. The prevalence of 
cancer in patients with symptomatic FAP ranges from 47 to 67%. Studies 
show that, although diagnosed, 59% of patients die of colorectal cancer 
due to extensive metastasis [2]. In 1951, Gardner reported the association 
between surface tumors and colon polyps that are prone to malignant 
degeneration. In 1952, Gardner and Plenk described the dominant 
heritage pattern of multiple osteomas associated with colonic polyposis. 
In the same year Gardner and Richards reported the association between 
colonic polyposis and osteomas with multiple cutaneous and 
subcutaneous tumors. This was how Gardner's Syndrome was 
discovered [3]. This syndrome has several phenotypic characteristics and 
among them are several changes in the oral cavity. Thus, the dentist plays 
a key role in detecting lesions that may be present in the oral cavity, 
helping in the early diagnosis of the disease [4]. 
 
Materials and Methods 
 
A literature search was performed using the scientific databases 
PubMed, Science Direct, B-on and Elsevier. Used keywords were 
Gardner syndrome; Familial adenomatous polyposis; Osteoma; Genetic 
disease; Supernumerary teeth. Scientific articles from 1992 to 2018 were 
selected. 
 
I Clinical Manifestations 
 
i Gastrointestinal Tract and Adjacent Structures 
 
The most important clinical manifestation of GS is the appearance of 
hundreds of adenomas (polyps) of different sizes in the colon that start 
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to develop around 16 years of age [5]. However, the colon is not the only 
part of the gastrointestinal system to be affected. In fact, 90% of patients 
with FAP develop polyps in the stomach fundus, but these polyps rarely 
cause cancer. In 90% of cases, polyps also appear in the duodenum and 
periampular region, with a 5% probability of malignancy. Pancreatitis 
can be a consequence of an adenoma in this region. Finally, intestinal 
adenomas may be involved but have low risk of being malignant [1]. 
 
ii Endocrine System 
 
Many studies have shown an association between GS and endocrine 
disorders with the appearance of thyroid nodules, craniopharyngioma 
and thyroid cancer [6]. The risk of thyroid cancer for GS patients is 100 
times higher than for the general population. The most common 
neoplasm is papillary thyroid carcinoma and affects 17 times more 
women than men. The average age of onset of this cancer is 23.6 [5, 7]. 
 
iii Ocular System 
 
About 80% of FAP patients have congenital hypertrophy of the retinal 
pigment epithelium (HCEPR), but this is not a specific symptom of this 
disease. Almost all patients with this feature have no symptoms [1, 6]. 
Examination of the fundus reveals multiple egg-shaped hyperpigmented 
retinal lesions, surrounded by a depigmented halo, in both eyes [8]. 
However, when multiple bilateral lesions occur, it may be a sensitive 
phenotypic marker of FAP. Few adenocarcinomas have been described 




There are also phenotypic manifestations of GS at the skin level. The 
presence of squamous cysts is considered the most common skin lesion 
and can appear on the face, scalp and less frequently at the body 
extremeties. Studies show that 50 to 65% of these patients have multiple 
cysts that are asymptomatic but may cause inflammation, itching and 
may even rupture [9, 10]. Other lesions such as hepatocellular 
carcinoma, fibromas, lipomas, leiomyomas, neurofibromatomas and 
pigmented skin lesions have also been reported, but have no tendency to 
malignancy [6]. Finally, patients with FAP may develop soft tissue 
tumors usually called desmoid tumors that appear in the mesentery, 
abdominal wall or scar areas. They are considered benign but the 
consequent pressure on the gastrointestinal or urinary tracts, as well as 
on the nervous or vascular systems can be fatal. The incidence of 
desmoid tumors in patients with FAP is approximately 8% in men and 
13% in women [1, 11]. 
 
v Oral Cavity 
 
Some manifestations of GS are observed at the oral cavity level. Between 
30 and 75% of GS patients have dental anomalies [9] including dental 
agenesis, enclosed teeth, delays in tooth eruption, dentigerous cysts, 
odontomas, supernumerary teeth, root fusion and hypercementosis [5, 
10]. As can be seen in (Table 1) the frequency of some types of dental 
changes is significantly higher in GS patients when compared with the 
general population. 
 
Supernumerary teeth can be single (isolated) or multiple. The single or 
double cases are usually located in the anterior region of the maxilla and 
the multiples are mainly found in the premolar region of the mandible. 
Eruption delay of a normal tooth may also be an early sign of a 
supernumerary tooth and thus favor the development of enclosed teeth 
[13]. The odontoma is a benign odontogenic tumor of the jaws with 
epithelium-conective tissue origin that is composed, in varied 
proportions, by the tissues involved in odontogenesis. It has no typical 
dental morphology, which allows to be distinguished from a 
supernumerary tooth [14]. There are two types of odontomas that can be 
distinguished clinically, radiologically and histologically: the complex 
odontoma in which dental hard tissues are presented as a diffuse mass 
without any sign of organization; and the composite odontoma, 
consisting of structures similar to multiple teeth, but separated from each 
other by connective tissue [13]. 
 
Table 1: Incidence of dental changes in patients with GS and in the 
general population [12]. 
 Supernumerary 
teeth 
Enclosed teeth Odontomas 
GS patients 11-27% 4-38% 9,4-83,3% 
General 
population  
0-4% 0-4% 0-4% 
 
Some studies also report that 68-82% of GS patients have osteomas, 
consisting of a benign lesion of well-differentiated mature bone tissue 
with predominantly laminar structure [15-17]. The presence of multiple 
lesions is usually common in GS patients, being the most common site 
the mandible. However, osteomas may also develop in the maxilla and 
skull [15, 18]. Central or lobulated osteomas can be seen in the mandible 
and, while central osteomas appear near the root of the teeth, lobules 
appear in the cortex and are more common in the mandibular angle [19]. 
Although usually asymptomatic and with very slow evolution, this lesion 
can reach significant proportions, causing distortion of the face, chewing 
disorders and limitation of mouth opening. In some cases, compression 
of adjacent organs may occur, which may cause swallowing and 
breathing disorders [18]. The pathogenesis of osteomas remains 
unknown [16]. 
 
II Genetic Characteristics of GS 
 
As noted above, GS is a genetic disorder with autosomal dominant 
transmission. Therefore, most individuals with this syndrome have a 
family history of this condition. However, up to 30% of patients may 
have a new dominant mutation (de novo mutation) and be the first 
affected member of the family [2]. Genetic changes that lead to the 
development of this condition involve the APC gene (adenomatous 
polyposis coli) [20]. 
 
i The APC Gene 
 
The APC gene was isolated in 1991. It is a tumour suppressor gene with 
locus 5(q21-q22). This gene is 300 kb long and consists of 15 exons of 
different sizes. By alternative splicing, part of exon 9 (nucleotides 934-
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1236) may be removed along with the exon's flanking introns, giving rise 
to a shorter mRNA. The coding region of the largest transcript comprises 
8,535 nucleotides [21]. APC protein can be divided into three regions: 
 
• The N-terminal portion (900 amino acids) is proline free and 
consists of eleven repeats of a helicoidal structures composed of a 
characteristic 7 amino acid sequence. The presence of this helical 
structure suggests a possible homodimerization and/or 
dimerization with other polypeptide chains. In fact, it was 
demonstrated that this region is responsible for protein 
homodimerization [22, 23].  
• The central region has 7 repeats of a 20 amino acids motif. It was 
found that the protein immunoprecipitated APC leads to the co-
purification of other proteins that have been identified as α-catenin 
and β-catenin. It is this central region of the APC protein that is 
responsible for this interaction [23].  
• The C-terminal end is involved in the association with tubulin, 
inducing the assembly of these filaments in vitro. This terminal 
contains a region rich in basic amino acids [24, 25]. 
 
APC is a classic tumor suppressor protein that plays a central role in Wnt 
signaling, being involved in the regulation of β-catenin degeneration. 
Wnt signals influence the stability of a protein complex containing β-
catenin, condutin and glycogen synthase kinase 3 (GSK3). In the absence 
of Wnt or in the presence of APC, β-catenin degradation occurs. On the 
other hand, in the presence of Wnt or in the absence of APC, as is the 
case with many colon cancers, β-catenin target genes, including c-myc, 
are expressed. The expression of the Myc protein leads to the expression 
of the polyamine ornithine decarboxylase which is a proto-oncogene [1]. 
APC also participates in other key cellular processes such as adhesion, 
migration, actin and microtubule network organization, spindle 




β-Catenin is associated with the cytoplasmic end of cadherin E, an 
adhesion molecule (also called uvomorulin) important in 
morphogenesis. The E-cadherin-catenin interaction is essential for 
maintaining epithelial cell adhesion [27]. APC modulates the interaction 
between cadherins and catenins, altering the mechanisms by which 
intercellular interactions control cell growth and differentiation [27]. 
APC protein can cause epithelial cell release in the intestinal lumen, 
preventing the retention of proliferating cells at the level of the intestinal 
ridges [27]. 
 
iii Mutations in the APC Gene 
 
Many mutated forms of this gene have been found in the germline of 
patients with familial polyposis. These changes are of various types and 
include point mutations, short deletions (1-14 nucleotides) or insertions 
(1-2 nucleotides). These changes particularly affect the 5' end of the APC 
gene. Approximately 70% of the mutations are located in the 5' portion 
of exon 15 (codons 713-1597) [21, 28]. The two most frequent deletions 
are of codons 1309 (20% of cases) and 1061 (10% of cases). These 
deletions lead to changes in the reading coding frame which results in 
the appearance of a premature stop codon and consequent synthesis of a 
truncated, poorly functioning or non-functional APC protein. However, 
this mutated protein is able to associate with the normal protein and lead 
to its inactivation, thereby exerting a negative activity [23, 25]. Only 
mutant forms of the protein that contain the catenin binding domain are 
able to associate with it [23, 25]. These truncated proteins can no longer 
associate with cytoskeleton microtubules [23, 25]. Studies suggest a 
correlation between mutation location and the number of developed 
polyps. Thus, mutations affecting codons 1,285 to 1,465 appear to be 
associated with profuse polyposis (more than 5,000 polyps). On the other 
hand, attenuated forms of familial polyposis (number of polyps generally 
below 100) result from mutations in the 5' end of the APC gene [29]. 
More than 1,400 different mutations in this gene have been identified. 
The mutated region of the APC gene determines extracolonic events as 
well as the time period and malignant potential of adenomatous polyps 
[30]. 
 
Furthermore, it has been reported that mutations in the MYH gene and 
environmental factors such as diet, exercise and smoking also play an 
important role in the pathogenesis of GS, which classifies this syndrome 
as a polygenic and multifactorial disease [30]. 
 
III Diagnosis of GS 
 
The diagnosis of this syndrome is based primarily on family history. In 
a second place, clinical diagnosis is performed that must be confirmed 
by genetic tests. Often, due to the development of psychomotor disorders 
or mental retardation, cytogenetic analyzes are performed at a young age. 
However, when there is no development of mental retardation and both 
parents are healthy, the disease will only be detected later in adolescence 
[1, 7]. 
 
i Clinical Diagnosis 
 
The first visible symptoms are osteomas and dental anomalies. The 
dental doctor may be the first health professional to suspect of the 
presence of this syndrome, by the use of palpation methods and 
panoramic radiography. Osteomas precede the formation of intestinal 
polyps, so they may be good markers for the disease [31, 32]. As 
discussed earlier, HCEPR is reported in 80% of GS patients and appears 
shortly after birth and may also represent the first sign of syndrome 
detection [6]. Osteomas can be detected by observing a bulge under the 
skin at the face level, however radiography remains the best detection 
method. Radiologically, osteomas present as a dense, well-
circumscribed, sometimes lobulated, uniformly radiopaque mass, often 
overlapping the underlying bone. Standard radiography (panoramic or 
retro-alveolar radiography) remains the first-line examination and 
should be complemented by three-dimensional imaging (computed 
tomography or cone beam), which is the reference image in the diagnosis 
of osteoma. Bone scintigraphy is especially useful for early diagnosis 
and as a guide for more accurate complementary examinations. 
Magnetic resonance imaging (MRI) is most suitable in cases where the 
medullary bone is affected or to guide the diagnosis when other imaging 
techniques are not conclusive. The differential diagnosis concerns 
exostosis, osteoid osteoma, odontoma and osteoblastoma [18, 33]. 
Regarding dental changes, the presence of an included supernumerary 
tooth in the oral cavity may be one of the signs and symptoms indicative 
of the presence of this syndrome. The most frequent dental signs are 
characterized by retention of one or more deciduous teeth, persistence of 
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the interincisal diastema, movements of neighboring teeth and articular 
teeth disorders [34]. Hyperdontics may be associated with other dental 
abnormalities such as fusion, agenesis, evagination or concrescence [35]. 
Oral cavity pain is the main clinical sign but there may also be 
dermatological signs such as angiokeratomas [36]. 
 
Supernumerary teeth are often asymptomatic and are discovered by 
panoramic, retro- alveolar, occlusal or cone beam radiography. Any of 
these techniques can determine the position, size and orientation of 
supernumerary teeth [37]. These supernumerary teeth can have three 
different locations: the conical or tubercular mesiodens that are usually 
in the palatal position relative to the central incisors; the molar-shaped 
paramolar that develops between premolars or molars, or exceptionally 
on the palatal or lingual side; or the distomolar that develops behind the 
wisdom tooth [13, 38]. When GS diagnosis is suspected, the patient is 
referred for gastroenterology consultation. A colonoscopy will confirm 
the presence or absence of intestinal polyps. These polyps may cause 
constipation, diarrhea, intestinal pain or rectal bleeding and may alert the 
physician to the disease [7]. 
 
ii Differential Diagnosis 
 
GS can be associated and distinguished from other forms of FAP, as 
shown in (Table 2). 
 
Table 2: Characteristics of different forms of FAP [5, 39]. 
 
 Classical form of FAP Attenuated form of FAP Gardner syndrome Turcot syndrome 
Gene APC: 5q21 APC: 5q21  
N-terminal mutation 
APC: 5q21 APC: 5q21 
Transmission Autosomal dominant Autosomal dominant Autosomal dominant Autosomal dominant 
Colic manifestations Adenomatous polyps Adenomatous polyps, late 
onset, low number 
Adenomatous polyps Adenomatous polyps 
Extra-colic 
manifestations 
Absent Absent HCEPR, epidermoid cysts, 
pilomatrixoma, fibrous 
hyperplasia, desmoid tumour, 
multiple osteomas 
various digestive tumours 




Basal cell carcinoma. 
Brown spots. 
Evolution Colonic adenocarcinoma More or less favorable Appearance of polyps: second 
and third decades. 
Cancers: third and fourth 
decades. 
Colon cancer – Nervous 
system disorders. 
 
iii Genetic Diagnosis  
 
After clinical diagnosis, GS should be confirmed by genetic testing. 
Nowadays, several genetic tests are available to detect germline 
mutations in the APC gene [40]. Complete gene sequencing is the most 
sensitive method for the detection of these mutations (70%), but it is time 
consuming, intensive and expensive. Alternatively, the protein 
truncation test has the advantage of being less expensive despite the 
lower detection rate of gene mutations. Southern blot analysis can be 
used to detect partial or total gene deletions or other major 
rearrangements [1, 40]. 
 
iv Prenatal Diagnosis 
 
Identification of the mutant APC gene responsible for FAP allows pre-
symptomatic and even prenatal diagnosis of the disease. In fact, if a 
mutation is identified in a family member, prenatal testing may be 
performed [1]. There are two conventional tests to look for the possible 
presence of mutation. The first is amniocentesis which is the most 
common, being performed with a small needle that is inserted through 
the abdomen and uterus into the amniotic sac to collect approximately 
30 mL of amniotic fluid. The exam is done between the 16th and 20th 
weeks of pregnancy. The second is called CVS (Chorionic Villous 
Sampling) and is performed between the 10th and 12th weeks, allowing 
earlier results. CVS is usually performed trans-cervically, with the 
insertion of a thin plastic tube into the placenta, and the suction of a small 
sample of chorionic villous tissue [1]. There are ethical issues associated 
with these prenatal diagnoses since the result might lead to the decision 
of pregnancy arrest. The answer to this complex problem is affected by 
cultural and religious factors. Studies show that only 20% of prenatally 
diagnosed women decide to abort when a mutation in the APC gene is 
detected [1]. During pregnancy, due to changes in multiple growth 
factors and endogenous hormones, women have an increased risk of 
development of demoid tumors and adenomas. During this period, 




In order to reduce morbidity and mortality, various types of surgery are 
used to eliminate the risk of colorectal cancer while preserving 
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neighbouring anatomical functions. Types of surgery include total 
ileorectal anastomosis colectomy, ileal pouch anal anastomosis 
proctocolectomy, and ileostomy proctocolectomy [39]. Ileorectal 
anastomosis colectomy seems to be the recommended treatment for 
patients with GS and colon polyps [39]. Ileostomy is only used in cases 
of recurrent neoplasms after an ileorectomy [39]. The complete removal 
of desmoid tumours, which are often invasive, can be very difficult. 
Some studies suggest the use of drugs, such as nonsteroidal anti-
inflammatory drugs (sulindac), tamoxifen or ascorbate, to temporarily 
reduce the number and volume of polyps [2]. Chemotherapy and 
radiotherapy may also be used. However, it is often difficult to control 
these recurrent, morbid or even fatal tumours [2]. Oral calcium has also 
been shown to inhibit rectal epithelial proliferation because of its ability 
to reduce colorectal cell turnover [39]. The treatment of osteomas 
consists of complete surgical excision of the lesion and the prognosis is 
excellent. The surgical approach may be intraoral or extraoral. For 
mandibular localization, if possible, intraoral rather than external access 
is preferred to avoid possible facial nerve injury [41, 42]. However, in 
some cases, the location of the lesion makes it impossible to perform 
intraoral surgery due to difficult access. It should be noted that some 
cases of spontaneous remission of osteoid osteoma were observed. 
Although osteoma recurrence is extremely rare, the patient should be 
followed for a long period of time after surgical removal of the primary 
lesion to control the evolution of healing [41, 42]. 
 
The treatment of supernumerary teeth will depend on its type and 
position and on possible complications. There is no consensus on when 
the best time for removal of the supernumerary teeth is [43]. However, 
in most cases, extraction is the treatment of choice. After extraction, 
orthodontic treatment may be useful to maintain sufficient clearance or 
to allow traction of the misplaced tooth. In some cases, when the 
supernumerary tooth is clinically and radiologically asymptomatic or 
when it is deeply embedded, therapeutic abstention and regular 
radiological examinations are decided on patient follow-up. When 
needed, treatments should be done as soon as possible to minimize 
complications [36]. 
 
Discussion and Conclusion 
 
GS is distinguished from FAP by the presence of extra-colonic clinical 
manifestations. The genetic cause of this syndrome has been identified 
as the presence of mutations in the APC gene [30]. The protein encoded 
by this gene is a key molecule in the Wnt signaling pathway, which is 
involved in the development of teeth and bones [44]. This pathway is 
expressed in the human oral epithelium during the morphogenetic stages 
of dental development [45]. It has been shown in the oral epithelium of 
rat embryos that APC ablation and Wnt/β-catenin activation result in the 
development of supernumerary teeth [46]. Regarding bone development, 
the association between the APC protein, differentiation of skeletal 
precursors and osteogenesis was confirmed. Mutations in the APC gene 
result in high osteoblast activity and increased bone deposition 
associated with high levels of β-catenin. Thus, patients with FAP have 
significantly higher bone mineral density when compared to healthy 
individuals of the same age and sex [47]. Oral mucosa vascular changes 
have also been associated with FAP [48]. All this explains the presence 
of Garner Syndrome symptoms in the oral cavity. On the other hand, the 
heterogeneity of clinical manifestations observed in this syndrome can 
be explained by other factors such as non-genetic environmental factors, 
not involving changes in the APC gene [26]. 
 
GS is characterized by the development of numerous rectal adenomas 
that may lead to colorectal cancer. However, manifestations in the oral 
cavity develop even before the appearance of adenomas. For this reason, 
the dentist may be the first health professional to be involved in the 
diagnosis of the disease. This clearly shows the dentist's power and duty 
in diagnosing systemic genetic diseases because of his ability to detect 
early oral cavity anomalies and thus refer the patient to more specialized 
services. Therefore, the management of genetic diseases is 
multidisciplinary, and the dentist can be an important link in this chain. 
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